Article
A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects with Various CYP2C9 Genotypes under Different Cotreatments.
Drug metabolism and disposition: the biological fate of chemicals - 1 Feb 2023
Cheng Shen, Flora Darcy R, Rettie Allan E, Brundage Richard C, Tracy Timothy S
Abstract excerpt
Warfarin, a commonly prescribed oral anticoagulant medication, is highly effective in treating deep vein thrombosis and pulmonary embolism. However, the clinical dosing of warfarin is complicated by high interindividual variability in drug exposure and response and its narrow therapeutic index. CYP2C9 genetic polymorphism and drug-drug interactions (DDIs) are substantial contributors to this high variability of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
